Introduction
The enzyme dihydropteridine reductase (EC 1. 6 2 ] (1) to 5,6,7 ,8-tetrahydrobiopterin which is the substrate for the aromatic amino acid hydroxylases: phenylalanine (EC 1.14.16.1), tyrosine (EC 1.14.16.2) and tryptophan (EC 1.14. 16.4) hydroxylases. It is a vital enzyme in mammals and its absence in humans brings about death at an early age (1) . The deficiency is clinically known a s hyperphenylalaninaemia which is a variant of phenylkentonuria (2) . The reductase has been isolated from various animal tissues and from two bacteria (3) .
.99.10) is essential for reducing the natural pteridine cofactor 2-amino-( 6R)-6[(1 ' R ,2' S)-1 ' ,2' -dihydroxypropyl]-7 ,8(6H)-dihydropteridin-4-one, L-erythro-(6R)-7,8(6H)-dihydrobiopterin [q(6R)-BH
The previous difficulties in obtaining the natural cofactor had made people use simpler and cheaper pterins , e. g. reduced 6.7-dimethylpterin, which were found to have good cofactor activity. The name " Pterin" is now generally used for the class of pteridines that possess a 2-aminopteridin-4-one nucleus. The name was suggested by Professor Wolfgang Pfleiderer in 1964 (4) which made it simple for biochemists and biologists. They have adopted it universall y because a large number of pteridines involved in metabolic processes have the 2-aminopteridin-4-one structure, having been derived from guanosine triphosphate.
'" This paper is dedicated to Professor Dr. Dr. h . c. Wolfga ng Pfleiderer on the occa sion o f his 60th birthday and in gra titude for his advice, friendship and generous hospitality over man y yea rs. The reduced 6-methyl (2) and 6,7 -dimethyl (3) pterins have been commonly used for assaying the reductase . In addition to being good substrates (see Tables 2 a nd 3), their precursors. th e corresponding 5,6,7,8-tetrahydropterins are commercially available at a reasonable price. The viability of the simple alkyl substituted quinonoid 7.8(6H)-dihydropterins as substrates for DHPR has stimulated studies of other derivatives as possible substrates to provide information about the space requirements at the active site (5), the precise tautomeric structure of the pyrimidine ring (6) and the minimum requirements for enzymic activity (7) . Further studies were made in order to improve the fat solubility of the pterin substrates as alternatives to the natural cofactor so that the precursor tetrahydropterins could penetrate the blood-brain-barrier more easily than the natural cofactor tetrahydrobiopterin (8 -10) . Kapatos and Kaufman (11) had previously shown that 6-methyl-5,6,7 ,8-tetrahydropterin penetrates the blood-brain-barrier ten times more effecti vely than L-ery thro -5,6,7 ,8- (5) . The second ~u bstrate for the reductase is the reduced pyridine nucleotide NADH which is the electron source for the reduction (Scheme 1). Kinetic studies are consistent with an ordered bi-bi mechanism in which ;\"AOH tirst binds very tightly to the enzyme, this is follo\\ed by the quinonoid pterin. The rate limiting step is an isomerisation, a conformational change. of the ternary complex, which is followed by rapid "hydride" transfer from NADH, and then by rapid release of tetrahydropterin and NAD-(oxidised pyridine nucleotide) in this order (14. 15) . The "hydride" from NADH is transferred from the "B" face, i. e. the 4-proS-hydrogen atom (16) .
The Assay
The assays all differ in the manner in which the quinonoid dihydropterin substrates are generated and the order of addition of ingredients. Once the substrate is generated , then in the presence of reductase, NADH is oxidised to NAD + with consequent increase in UV absorbance at 340 nm. The reaction extinction coefficient is usually taken as 6200 M -1 cm -1. The initial rates are measured from the linear scan of absorbance versus time at 340 nm. The most widely used oxidant is peroxidase-hydrogen peroxide (A) (17, lS) or peroxidase and oxygen (19) or some modification of these (B), bromine (C) (20) , 2,6-dichlorophenolindophenol (D) (17, 21) , ferric iron (E) (21) , potassium ferricyanide (F) (17, 21) , ferri-cytochrome c (G) (22) , and the coupled assay with phenylalanine hydroxylase and oxygen (H) (1S). This alphabetical order is used in the Tables. The most commonly used method has been (A), but whenever two or more methods were used by the same authors the values of the kinetic parameters obtained by the different methods were generally, but not always, within experimental error. The success of the assays A to F rely on the rapid and almost quantitative conversion of the tetrahydropterin, e. g. (5) to the quinonoid dihydropterin, e. g. (4) , so that this oxidation is not rate limiting. The oxidant is usually in excess making the concentration of quinonoid species constant during the measurement of initial rates, because the tetrahydropteridine produced by reduction with DHPR and NADH is very rapidly re-oxidised to the quinonoid species. The concentration of the quinonoid species is therefore taken as being equal to the concentration o f the tetrahydropteridine originally used. The concentration of NADH consequently decreases during the assay, and it is imperative that the initial concentration of NADH is at saturating le\"els when determining the kinetic parameters of the pteridine substrate. Another feature that should be taken into account is the stability of the quinonoid pteridine which should be determined {J priori. These species rearrange to the enzymically inactive 7,8(3H)-dihydropteridines. The rates of the rearrangements can be readily determined by oxidising the tetrahydropteridine to the quinonoid species, e. g. with peroxidase and hydrogen peroxide which are essentially UV transparent, and observing the characteristic UV spectral changes. Since this rearrangement is acid-base catalysed (12, 13) then the rate depends on the buffer used. For the examples that have been studied the rates of rearrangement are slowest in Tris-HCI buffer; that is why most of the reported work has been carried out in Tris-HCI buffer. It is important that the rate of rearrangement is slow compared to the enzymic reaction, so that it does not seriously affect the concentration of active pteridine during the initial rate measurements. The optimal pH for the reductase is in the range ca. 7.0 -7.5, within which the non-enzymic rates of NADH oxidation arc not noticeably altered (lS, 23). The pH values of the solutions should always be measured at the completion of each run. Most of the data in the tables were obtained in Tris-HCI buffer (ca. 50-100 mM) in the above pH range; using the racemic (at C6) substrates unless otherwise stated.
The Kinetic Parameters
All the substrates listed in the tables exhibit MichaelisMenten (24) kinetics, i. e. saturation kinetics, and are therefore amenable for kinetic studies and successful initial rate measurements. Two substrates, the quinonoid dihydropterin and NADH, are used in the reaction catalysed by DHPR and the initial rates are governed by the Michaelis-Menten equation (25) . If the concentration of one of the substrates (e. g. NADH) is close to, at or above saturating levels for the enzyme and substrate S, then the equation reduces to (i).
Where v is the initial rate of the reaction, V is the maximum velocity, [S] is the concentration of one substrate, e. g. quinonoid pterin, and Krn is its Michaelis constant. A Lineweaver-Burk (26) plot, i. e. a plot of l /v versus l /[S] yields a straight line from which the kinetic parameters V max and K m can be derived. The determination of these parameters from a plot are not very accurate and do not give any idea of the errors involved. Computer programmes are now available for the more accurate evaluation of these parameters and their errors (27, 28) . Both methods were used to derive the data in the Tables. Those obtained by the latter method are more useful because the errors also give some indication of the reliability of the measurements. Most of the data in the Tables did not come from extensive detailed studies, i. e. using two substrates at various concentrations, highly purified enzymes etc. , consequently most of the K m , V m ax and V /K parameters are apparent values. Almost all the parameters for the pteridines in the Tables were determined at, or close to, saturating concentrations of pyridine nucleotides. In samples where the concentrations of pyridine nucleotide are far below sa turation then the kinetic parameters are unreliable for comparisons because none of the measurements were analysed completely to take the rate of change of nucleotide concentration into acco unt. The Km values for NADH are collected in Table 1 together with data for NADPH in square brackets. The K ill values for NADH are all in the low micro molar range, and as a rule of thumb concentrations of co 5 -8 x Km are close to saturation. A rapid way to see if the second substrate is at a concentration which saturates the enzyme is to double the concentration of substrate, while keeping all other ingredients and conditions constant, and observing the new rate. If the second substrate is at saturating concentrations then doubling this concentration should not alter the rate. The detailed method requires the measurement of the Km of the second substrate and makes sure that its concentration is > SK m • This is not always possible, however, because of inhibition by the substrate that is in excess. A large number of measurements in which the concentrations of both substrates a re varied over a wide range are required for obtaining the true parameters.
Three kinetic parameters are of particular importance for comparing the effectiveness of substrates. They are the Km, V max and V /K values. These values will be discussed in terms of one substrate, i. e. equation (i), because the data in the Tables 2-10 are most probably all derived with this equation and with the concentration of the second substrate at, or assumed to be at, saturating levels. The first parameter, the Michaelis constant Km, is usually taken to mean the binding ability of the substrate to the enzyme. The smaller the value, the tighter the binding. Although this could roughly be true, it is not strictly so because it includes a term for the rate of formation of products (29) . For example, by using fluorescence and ligand partition methods Lind (30) found that the dissociation constants of the binary complexes of 6-methyl-7,8(6H)-dihydropterin (2) and NADH with DHPR from rat liver were 2 -3 11M and 0.07 11M in 0 .1 M Tris-HCI buffer at pH 6.8 and 30 D C respectively. Under these conditions the respective Km values were 30 11M and 1.05 11M. The apparent Km, however, was equal to the dissociation constant of the ternary complex and was consistent with a random bi-bi mechanism.
The second parameter, the maximum velocity V max. is the rate of the reaction at saturating levels of the substrate and is proportional to the quantity of enzyme used. For one mole of enzyme (or one active site per subunit) the V max is equal to k cat , the turnover number. The larger the V max the faster the substrate turnsover on the enzyme. It should be noted that in comparisons where the same amount of enzyme was used then the ratios of V ma x of two substrates is the ratio of their turnover numbers. The third useful parameter the V /K or kcat/K is in fact the first order rate constant at concentrations of substrate considerably less than the Km va lue. Thus when Km
The larger the value of V /K the better the substrate when using the same amount of enzyme. For one mole of enzyme (with one active site) this becomes k cat/K.
Th e reduced pyridine nucleo tide
The effects of structural changes in the pyridine nucleotide have not been explored but the reduced phosphate NADPH has been examined as a possible substrate. In all cases studied it was found to be a substrate but it was less efficient than NADH (17, 18) and the Km values for NADH were smaller than for NADPH. There are, however, a few specific dihydropteridine reductases which use NADPH more efficiently than NADH but they are different proteins from the more abundant reductases. They are the second human and bovine liver reductases (31) and four isoenzymes from silkworm (32) .
Discussion of the Data in the Tables
In the following discussion the effect of substituents on the DHPR activity of quinonoid 7,8(6Hl-dihydropterins are reviewed. The 6,7-dimethyl, 6-methyl and biopterin derivatives, in this order, are discussed first because a large number of measurements have been reported on these compounds (cfTables 2, 3 and 4). These are followed by the effects of methyl and other groups in various positions of the pteridine ring on DHPR activity.
Quinonoid 6,7-dimethyl-7,8 ( 6H ) -dihydropterin
The data for quinonoid 6,7-dimethyl-7,8(6H)-dihydropterin are collected in Table 2 . This is the largest collection of data for one substrate mainly because
the precursor tetrahydro derivative is the easiest compound to make and cheapest to buy. Also it is quite a good substrate; compare with the 6-methyl derivative in Table 3 cis dimethyl compound the 6 and 7 methyl groups are axial a nd equatorial in one extreme conformation, and equatorial and axia l in the other extreme conformation respectively. The Km values for the 6,7-dimethylpterins range from 0.73 to 59 11M and fo r DHPR from the same source, e. g. human liver, the va lues vary from 3.3 to 36 11M ( Table 2 ). The difference is mainly due to the care in which the kinetics were performed and the method used to evaluate the data, e. g. by computer analysis or by double reciprocal plots, but only to a small extent on the purity of the enzyme. The V ma" on the other hand , is dependent on the purity and quantity of enzyme used . 
Quinonoid 6-methy l-7,8 (6H ) -dihydropterin
The data in Table 3 show that the 6-methyl derivative is marginally a better substrate than the 6,7-dimethyl derivative and that it 'turns over' better. The d ata a lso show that the absolute configuration at C6 in the 6-methyl derivative is not very important (see above), and that the active site will accommodate the two extreme conformations as long as the 6-methyl substituent is equatorial (5) . All the measurements of 6-methyl-7,8(6H)-dimethylp terin (Table 3) show variations in the Km values which are mainly within experimental error. The V m" x values reflect the purity of the enzyme. 
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Quinonoid dihydrobiopterin and neopterin
The parameters for quinonoid dihydrobiopterin for mammalian DHPRs show interesting features (Table  4) . This compound is a 6-substituted derivative with a 6-(1 ',2'-dihydroxypropyl) side-chain (1 values for the natural 6R isomer are in the low micromolar range whereas the values for the non-natural 6S isomer are an order of magnitude larger, i. e. probably due to weaker binding. Although the V max for the 6R isomer is about half the value for the 6S isomer, the overall V j K value for the natural isomer is larger as expected. Quinonoid dihydroneopterin is apparently not a natural substrate for mammalian DHPR yet it is a very effective substrate for the enzyme. It should be noted that the kinetic parameters for the bacterial (E. coli) enzyme indicate that the reduced biopterin is a relatively poorer substrate compared with mammalian DHPR. This is not unexpected in view that the natural cofactor for the bacterial enzyme is most probably the quinonoid dihydromonapterin (a stereoisomer of quninonoid dihydroneopterin) (33, 34) . Also the E. coli reductase (33), unlike other known dihydropteridine reductases, is a flavoprotein which possesses a pterin-independent potassium ferricyanide-dependent oxido-reductase activity and dihydrofolate reductase activity (35) . All the earlier measurements with the reduced biopterin derivative were carried out with mixtures of the 6R and 6S isomers in unspecified ratios. Quinonoid dihydroneopterin is also a good substrate for mammalian DHPR, but here again all measurements with quinonoid dihydroneopterin and related compounds were performed with mixtures of diastereoisomers at C6 of unstated ratios.
Minimum requirements for substrate activity
The data for a variety of quinonoid dihydropterins are in Table 5 . The simple quinonoid 7.8(6H)-dihydropterin is a good substrate, however because of the relative instability of the 6,6,7,7-protio compound due to rearrangement, the corresponding more stable tetradeuterio compound was studied. The complete 185 pteridine ring is not absolutely essential for substrate activity because 2,6-diamino-5-iminopyrimidin-4-one is a satisfactory substrate (6) . Substitution of the 6-amino group by a 6-methyl group is this pyrimidine totally abolishes substrate activity.
Substitution at the 2-and 4-positions
A substituent at position 2-, other than H , is not strictly necessary for enzyme activity, and 7,8(6H)-dihydroperidin-4-ones are viable substrates for DHPR ( Table 6 ). Replacement of the 2-amino group of the pteridine by 2-methylamino, 2-methylthio or 2-methyl groups does not remove substrate activity, indeed these are relatively satisfactory substrates (Table 5), and together with the data in Table 6 clearly demonstrate that the 2-amino group of the pteridine ring is not an absolute requirement for substrate activity. Moreover replacement of the 2-amino group by a 2-methyl group in reduced biopterin and neopterin [and also in reduced 7-methylpterin (cfTable 6)] decreases their effectiveness as substrates, but they do possess appreciable activity none-the-less (36). This is strong evidence for the tautomeric structures drawn in this report, and not the earlier tautomeric structure (6) with the exocyclic 2-imino group for the quinonoid substrates. Replacing the 4-oxo by a 4-thioxo group does not remove substrate activity, although these thioxo groups undergo oxidation during the perparation of the quinonoid species. This makes it very difficult to obtain even approximate kinetic parameters. Qunonoid 6-methyl-7,8(6H)-dihydrolumazine, on the other hand, is DHPR inactive (6, 37). 
The effect of the size of the side-chain at C6
In an endeavour to increase the fat solubility of tetrahydropterins for more favoura ble blood-brain-barrier penetration compared with tetrahydrobiopterin, a large variety of derivatives with carbon chains at C6 were studied. For effective drug use, it is imperative that their hydroxylase oxidation products, the respective quinonoid dihydropterins are good substrates for DHPR so that the drugs can be recycled.
Many of these compounds were tested and their kinetic parameters are listed in Tables 7 -1 O. Comparative studies were made with these examples and the data in the same tables were obtained by the same workers using similar conditions, which made the comparisons meaningful. The reductase tolerated a variety of alkyl and aralkyl side-chains at C6. Indeed as can be seen in Table 7 the kinetic parameters are extremely favourable (i . e. lower Km and higher V max values) when one substituent is at C6, and in fact some are better than the natural substrate q-(6R)-BH 2 (1) . These data together with the data for q-dihydrofolic acid ( Table 5 ), indicate that there is a hydrophobic pocket on the enzyme which can bind strongly with the C6 carbocyclic side-chain. Thus the 6-n-hexyl derivative is a better substrate than the 6-methyl derivative, and there are other examples supported by the data in Tables 7 a nd 8. The substrates in Table 8 further show that the C6 carbon side-chain can be interrupted by an oxygen or sulphur atom without adverse effects. The enzyme can also accommodate a branched alkyl side-chain at C6, e. g. neopentyl, with only a slight decrease in efficiency (Table 7) .
The effect of two alkyl substituents at C6
In another approach efforts were made to stabilize the quinonoid species by introducing gem-alk yl groups at C6, thus obviating the acid-base cata lysed rearrangement of quinonoid dihydropterins to 7,8(3H)-dihydropterins. A collection of such substrates (i. e. 7) is listed in Table 9 (see also Table 7 for the 6,6-dimethyl derivative). Although these are no t as effective as q-(6R)BH 2 (1) when the Km values a re compared, they are none-the-Iess satisfacto ry substrates. The second alkyl group at C6 does increase the Km value of the substrate with only a small cha nge in V max «(I Tables 7 and 9 ). Here the inserti o n of a phenyl substituent at C6, as well as a benzyl group, lowers the K m value considerably compared \\ ith a methyl group and confirms the postulate that there are strong hydrophobic interactions at the active site dose to C6 of the substrate. 
The effect of substituents at C7 Quinonoid 7-methyl-7,8(6H)-dihydropterin is as good a substrate as the 6-methyl isomer. Replacing the 7-methyl group by a 7-neopentyl group does not adversely interfere with activity, indicating that there is a large hydrophobic pocket around C7 also (cfTable 7). Insertion of a 7-methyl group to the 6-methyl 187 substrate (2), as in compound (3) has a very small effect on activity (see above); but addition of a second methyl group at C7 as in the 6,7,7-trimethyl derivative (8, R = Me) reduces, the V max value appreciably and increases the Km value resulting in decreased substrate activity (cf Tables 2 and 5) . Further examples of7,7-dimethyl derivatives (8) with hydrophobic substituents at C6 have been studied (Table 8) , and from the data available it appears that the strong hydrophobic interactions around C6 in the alkoxymethyl derivatives outweight the unfavourable effects of the additional methyl group at C7. = 100 flM .
The effect of an N8-melhyl group
The enzyme will tolerate a methyl group on N8 when another methyl group is at C6, albeit with decreased activity (Table 5 ). However, the activity is lost when there are two methyl groups at C6 in addition to the methyl group at N8 (38) .
Finally it was demonstrated that the hydropyrazinc ring can be enlarged to a hydrodiazepine ring (e. g. 9) with no apparent loss of DHPR activity (Table 10) .
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Conclusion
The data collected in this report demonstrate that DHPR from a variety of mammalian sources can tolerate a large number of substituents in both the hydropyrazine and the pyrimidine rings. It appears that the most important feature for substrate activity is the structure (10) with presumably the correct reducation potential. Formula (11) summarizes all the effects discussed above and demonstrates the space requirements at the active site for pteridine cofactors as deduced from the enzymic activities of the derivatives in the Tables . The large hydrophobic pocket around C6 is shown in formula (11) .
